Memorial Sloan Kettering Cancer Center

Harrison, New York 11533

0 studies enrolling now · 7 studies all time

What they study most

Acute Myelogenous Leukemia, Advanced Solid Tumor, Aggressive, Any Solid Tumor, B-cell Non-Hodgkin Lymphoma, Cholangiocarcinoma, Chondrosarcoma, Colorectal Cancer, Glioma, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer

Studies at this site

• Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations — Running, not enrolling
• A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. — Running, not enrolling
• A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer — Completed
• DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas — Running, not enrolling
• Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers — Completed
• Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) — Stopped early
• A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation — Stopped early